Login/Sign Up
(Inclusive of all Taxes)
Get Free delivery (₹99)
MEGVAL 50MG INJECTION is used to treat Multiple myeloma, advanced cancer of the ovaries, childhood neuroblastoma (cancer of the nervous system), malignant melanoma (skin cancer) and soft tissue sarcoma. It contains Melphalan, which reduces the number of abnormal cells your body makes. Thus, it treats cancer efficiently. The most common adverse reactions observed in patients treated with this medicine are neutrophil count decreased, white blood cell count decreased, platelet count decreased, lymphocyte count decreased, diarrhoea, fatigue, anaemia, nausea, vomiting and hypokalemia.
Provide Delivery Location
About MEGVAL 50MG INJECTION
MEGVAL 50MG INJECTION belongs to a class of alkylating agents, also known as chemotherapeutic agents. It is used to treat various cancer conditions such as multiple myeloma ((a type of cancer that develops from cells in the bone marrow called plasma cells), advanced cancer of the ovaries, childhood neuroblastoma (cancer of the nervous system), malignant melanoma (skin cancer) and soft tissue sarcoma. Cancer is a genetic change in which the body's cells divide uncontrollably and spread into surrounding tissues. MEGVAL 50MG INJECTION is also used to destroy bone marrow and cancer cells in preparation for a bone marrow transplant in people with multiple myeloma.
MEGVAL 50MG INJECTION contains Melphalan, which reduces the number of abnormal cells your body makes. Thus, it treats cancer efficiently.
MEGVAL 50MG INJECTION will be administered only in a hospital setting by an experienced healthcare professional. The most common adverse reactions observed in patients treated with MEGVAL 50MG INJECTION are neutrophil count decreased, white blood cell count decreased, platelet count decreased, lymphocyte count decreased, diarrhoea, fatigue, anaemia, nausea, vomiting and hypokalemia. Most of these side effects do not require medical attention and will resolve gradually. However, you are advised to talk to your doctor if any of these side effects persist or worsen.
Treatment with MEGVAL 50MG INJECTION is not advised during pregnancy since it may harm the fetus. If you are already pregnant, you should inform your doctor before receiving MEGVAL 50MG INJECTION. To avoid pregnancy while on treatment with MEGVAL 50MG INJECTION, you or your partner must use reliable contraceptive precautions. Inform you are doctor if you are breastfeeding.
Uses of MEGVAL 50MG INJECTION
MEGVAL 50MG INJECTION is used in the treatment of Multiple myeloma, advanced cancer of the ovaries, childhood neuroblastoma (cancer of the nervous system), malignant melanoma (skin cancer) and soft tissue sarcoma. The detailed uses of MEGVAL 50MG INJECTION are as follows:
Have a query?
Directions for Use
Medicinal Benefits
MEGVAL 50MG INJECTION is an alkylating medicine, also known as a chemotherapeutic agent, primarily used to treat various cancer conditions such as multiple myeloma (a type of cancer that develops from cells in the bone marrow called plasma cells), advanced cancer of the ovaries, childhood neuroblastoma (cancer of the nervous system), malignant melanoma (skin cancer) and soft tissue sarcoma. Melphalan, present in MEGVAL 50MG INJECTION, works by reducing the number of abnormal cells produced by your body. As a result, it effectively treats cancer.
How MEGVAL 50MG INJECTION Works
Storage
What if I have taken an overdose of MEGVAL 50MG INJECTION
Drug Warnings
Before taking MEGVAL 50MG INJECTION inform your doctor if you are pregnant or breastfeeding. If you become pregnant while on treatment with MEGVAL 50MG INJECTION, inform your doctor. Before taking MEGVAL 50MG INJECTION, inform your doctor about your medical history and ongoing therapies to rule out potential adverse effects or interactions. Always take MEGVAL 50MG INJECTION as prescribed by your doctor. It's crucial to take your medication as directed. The dosage of this medicine is based on your condition. Your doctor may adjust your dose during therapy based on the results of the treatment. If you have kidney issues, your doctor will usually give you a lower dose than other adults. Your doctor will determine if you should undergo preventive medication for blood clots in the veins. This applies during the first 5 months of treatment or if you have an elevated risk of developing a blood clot in your veins. The amount of blood cells in your bone marrow may drastically drop if you take MEGVAL 50MG INJECTION. In addition to raising your chance of getting a serious infection or bleeding, this could result in specific symptoms. Please contact your doctor right away if you encounter any of the following symptoms: abnormal bleeding or bruises; bloody or black, tarry stools; bloody vomit; or vomiting blood or brown material that resembles coffee grounds; fever, sore throat, persistent cough and congestion, or other symptoms of infection. Remember to keep all of your doctor's and the lab's appointments. Before and throughout your treatment, your doctor will order routine laboratory testing to determine whether this medication is having an impact on your blood cells. MEGVAL 50MG INJECTION may make you more susceptible to getting other cancers. Talk to your doctor to know more about MEGVAL 50MG INJECTION.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Alcohol
Caution
Avoid alcohol consumption while on treatment with MEGVAL 50MG INJECTION.
Pregnancy
Caution
MEGVAL 50MG INJECTION should not be used during pregnancy. So, inform your doctor if you are pregnant or suspect pregnancy. You or your partner must use a reliable form of contraception to prevent pregnancy while taking these medications.
Breast Feeding
Caution
If you are breastfeeding, inform your doctor. You should not breastfeed while on treatment with MEGVAL 50MG INJECTION.
Driving
Caution
It is unknown whether MEGVAL 50MG INJECTION alters the ability to drive, so do not drive or operate machinery if you experience any symptoms affecting your ability to concentrate and react.
Liver
Caution
If you have a pre-existing or a history of liver disease, inform your doctor before taking MEGVAL 50MG INJECTION.
Kidney
Caution
If you have a pre-existing or a history of kidney disease, inform your doctor before taking MEGVAL 50MG INJECTION. Your doctor may titrate the dose if required based on your condition.
Children
Caution
MEGVAL 50MG INJECTION is only not recommended for use in children as the safety and effectiveness have not been established.
Heart
MEGVAL 50MG INJECTION should be avoided in heart patients, especially those with a history of arrhythmias or cardiac dysfunction, due to its potential for cardiotoxicity and thromboembolic risks. If absolutely necessary, it must be administered under strict medical supervision with full cardiac monitoring.
Geriatrics
Caution
MEGVAL 50MG INJECTION may be used in geriatric patients, as studies have not shown age-specific limitations to its effectiveness. However, older adults often have reduced liver, kidney, or heart function, so cautious dosing and close monitoring are essential to minimize toxicity.
MEGVAL 50MG INJECTION is used to treat Multiple myeloma, advanced cancer of the ovaries, childhood neuroblastoma (cancer of the nervous system), malignant melanoma (skin cancer) and soft tissue sarcoma.
MEGVAL 50MG INJECTION contains Melphalan, which works by reducing the number of abnormal cells your body makes. Thus, it treats cancer efficiently.
While taking MEGVAL 50MG INJECTION, make sure to attend all of your doctor's appointments to ensure the therapy is effective. Blood tests and weight checks must be monitored on a regular basis. Both men and women should utilize an effective method of contraception while taking MEGVAL 50MG INJECTION.
Melphalan can cause a significant decrease in the number of blood cells and platelets. Your doctor may suggest laboratory tests before and during the treatment.
Country of origin
Manufacturer/Marketer address
Keep Refrigerated. Do not freeze.
We provide you with authentic, trustworthy and relevant information
Buy best Neoplastic Disorders products by
Intas Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Natco Pharma Ltd
Celon Laboratories Pvt Ltd
Cipla Ltd
Sun Pharmaceutical Industries Ltd
BDR Pharmaceuticals Internationals Pvt Ltd
Adley Formulations
Admac Lifesciences(Oncology)
Alkem Laboratories Ltd
Neon Laboratories Ltd
Glenmark Pharmaceuticals Ltd
United Biotech Pvt Ltd
Halsted Pharma Pvt Ltd
Emcure Pharmaceuticals Ltd
Zydus Healthcare Ltd
Zydus Cadila
Samarth Life Sciences Pvt Ltd
Mylan Pharmaceuticals Pvt Ltd
Hetero Drugs Ltd
GLS Pharma Ltd
Axiommax Oncology Pvt Ltd
Fresenius Kabi India Pvt Ltd
Hetero Healthcare Pvt Ltd
Torrent Pharmaceuticals Ltd
Pfizer Ltd
Getwell Life Sciences India Pvt Ltd
Khandelwal Laboratories Pvt Ltd
Lupin Ltd
Adley Pharmaceuticals Ltd
Cadila Healthcare Ltd
Aureate Healthcare
Novartis India Ltd
Therdose Pharma Pvt Ltd
RPG Life Sciences Ltd
Abbott India Ltd
Biochem Pharmaceutical Industries Ltd
Delarc Pharmaceuticals Pvt Ltd
Aimcad Biotech Pvt Ltd
Reliance Formulation Pvt Ltd
Shilpa Medicare Ltd
Wembrace Biopharma Pvt Ltd
Zee Laboratories Ltd
Msn Laboratories Pvt Ltd
Amps Biotech Biotech Pvt Ltd
Astra Zeneca Pharma India Ltd
Getwell Oncology Pvt Ltd
Caitlin Oncology
Medaegis Biotek Pvt Ltd
Dabur India Ltd
Del Trade International Pvt Ltd
MEDICAMEN BIOTECH LTD
Medion Biotech Pvt Ltd
Oncostar Pharma Pvt Ltd
Panacea Biotec Ltd
Sarabhai Chemicals (India) Pvt Ltd
Bhardwaj India Pvt Ltd
Getwell Pharmaceutical Pvt Ltd
Cytogen
Lucien Life Sciences
Symbion Lifescience
Bangalore Pharmaceutical and Research Laboratory Pvt Ltd (BPRL)
Cadila Pharmaceuticals Ltd
Miracalus Pharma Pvt Ltd
Vhb Life Sciences Inc
Allieva Pharma Pvt Ltd
Amneal Healthcare Pvt Ltd
Ipca Laboratories Ltd
Zuvius Lifesciences Pvt Ltd
Eli Lilly and Company (India) Pvt Ltd
Eris Life Sciences Ltd
Johnson & Johnson Pvt Ltd
Maximal Healthcare Pvt Ltd
Admac Pharma Ltd
Akumentis Healthcare Ltd
Biocon Ltd
Bruck Pharma Pvt Ltd
Caitlin Biotech Pvt Ltd
Ferring Pharmaceuticals Pvt Ltd
Fresenius Kabi Oncology Ltd
Hilfen Pharmaceuticals Pvt Ltd
Medicamen Biotech Ltd
Sayre Therapeutics Pvt Ltd
Zuventus Healthcare Ltd
Boehringer Ingelheim India Pvt Ltd
Selway Lifesciences Pvt Ltd
Trikem Remedies Llp
Adley Oncology
Corona Remedies Pvt Ltd
Eisai Pharmaceuticals India Pvt Ltd
GlaxoSmithKline Pharmaceuticals Ltd
Gynofem Healthcare Pvt Ltd
Hillrock Biotech Pvt Ltd
Janssen Pharmaceuticals Pvt Ltd
Jodas Expoim Pvt Ltd
Mankind Pharma Pvt Ltd
Merck Ltd
Oncobiotek Drugs Pvt Ltd
Pharm Products Pvt Ltd
Rhone Poulenc Rorer India Pvt Ltd